The influence of maternal COVID-19 on cardiac functions: From fetal life to infancy

Yasemin Özdemir Şahan1, Bedri Sakcak2, Şule Göncü Ayhan3

  • 1Department of Pediatric Cardiology, Turkish Ministry of Health, Ankara City Hospital, Ankara, Turkey.

PubMed

Insights

Maternal COVID-19 infection during pregnancy can negatively impact fetal and infant heart function. Studies show impaired cardiac performance in babies born to mothers with COVID-19, persisting into infancy.

Area of Science:

  • Cardiology
  • Maternal-Fetal Medicine
  • Infectious Diseases

Background:

  • Maternal COVID-19 infection during pregnancy.
  • Potential impact on fetal and child cardiac development.

Observation:

  • Case-control study comparing pregnant women with COVID-19 (second trimester) to healthy controls.
  • Fetal, neonatal, and infant cardiac functions assessed via echocardiography at multiple time points post-infection.

Findings:

  • Significantly increased interventricular septum and left ventricular posterior wall dimensions in fetuses and infants of mothers with COVID-19.
  • Impaired right and left ventricular diastolic function observed.
  • Elevated myocardial performance indexes noted in the study group compared to controls.

Implications:

  • Maternal COVID-19 has demonstrable short- and mid-term effects on fetal and infant cardiac function.
  • Suggests a need for cardiac monitoring in infants exposed to maternal COVID-19 in utero.
  • Highlights potential long-term cardiovascular health considerations for children born to mothers with COVID-19.
Abstract

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
980
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
947